Rchr
J-GLOBAL ID:200901076229508967   Update date: Jan. 30, 2024

Suzuki Toshihiro

スズキ トシヒロ | Suzuki Toshihiro
Affiliation and department:
Homepage URL  (1): http://www.my-pharm.ac.jp/~tssuzuki/home/index.html
Research field  (1): Tumor biology
Research keywords  (9): 3次元培養 ,  ハイスループット薬物評価系 ,  耐性克服剤の開発 ,  マイクロアレイ ,  肺癌 ,  Cisplatin ,  EGFR-TKI耐性 ,  MDR ,  Multi Drug Resistance Protein
Research theme for competitive and other funds  (10):
  • 2015 - 2018 Prediction of the phosphorylation signal response of receptor-type tyrosine kinase (RTK) inhibitors using miRNA as a biomarker.
  • 2012 - 2015 Prediction of sorafenib response by FGF3 gene amplification for patients with hepatocellular carcinoma
  • 2012 - 2015 Uptake mechanisms study and molecular analysis of biomedicine in tissue culture system.
  • 2010 - 2011 Construction of the miRNA database associate with chemotherapeutic sensitivity in lung cancer.
  • 2008 - 2009 Functional analysis of miRNA dependent cisplatin resistance mechanisms.
Show all
Papers (75):
more...
MISC (78):
more...
Works (4):
  • 新規プラチナ化合物のチオール結合性と耐性克服作用の解析
    2001 -
  • Study of Drug Resistance and its Circumvention on Novel Platinum Compounds.
    2001 -
  • 癌化学療法における薬剤耐性機構の解明
    2000 -
  • Study of Drug Resistance Mechanisms on Cancer Chemotherapy
    2000 -
Education (4):
  • - 1999 Meiji Pharmaceutical University
  • - 1999 Meiji Pharmaceutical University Graduate School, Division of Pharmaceutical Sciences
  • - 1994 Meiji Pharmaceutical University Faculty of Pharmacy
  • - 1994 Meiji Pharmaceutical University Faculty of Pharmaceutical Science
Professional career (1):
  • Ph. D (Meiji Pharmaceutical University)
Association Membership(s) (4):
日本薬学会 ,  日本癌学会 ,  日本生化学会 ,  日本がん分子標的治療学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page